Skip to main content

Animations

MJFF Publications

5671 - 5680 of 6466 Results
Title
Year
  • Year
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2020
  • 2013
  • 2021
  • 2023
  • 2015
  • Summary Details
    OPEN
    Title: The PET tracer [ 11 C]MODAG-005 targets alpha-synuclein aggregates in the brain
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aec0813
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Longitudinal Repeatome Remodeling in Peripheral Blood Following Parkinson’s Disease Diagnosis
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3390/genes17050577
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Regulator of G protein signaling 10: a critical regulator of chronic systemic inflammation in parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1186/s12974-026-03858-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parkinson's disease drug therapies in the clinical trial pipeline: 2015–2024
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/1877718x261454154
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Construct optimization for AAV-mediated human α-syn overexpression, and validation across research settings: Development of a shared tool for the research community
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/1877718x261447105
    Citation Count: 0
  • Summary Details
    OPEN
    Title: EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-020-04817-8
    Citation Count: 256
  • Summary Details
    OPEN
    Title: Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-013-1121-x
    Citation Count: 95
  • Summary Details
    OPEN
    Title: Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-021-10586-7
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29647
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Novel recruitment strategy to enrich forLRRK2mutation carriers
    Journal Name: Molecular Genetics & Genomic Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mgg3.151
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.